New diabetes drug proving helpful

Tue, 10 Jun 2008
According to recent news reports, Sanofi-Aventis diabetes drug Acomplia could help to improve blood sugar control amongst patients suffering from type 2 diabetes who are failing to control their condition using insulin therapy.

Sanofi, a French pharmaceutical company, have defended the drug following rejection as a weight loss treatment in America. The Food and Drug Administration rejected the drug due to fears that it could provoke suicidal thoughts.

Acomplia has faced a rocky road after clinical trials apparently revealed increased likelihood of anxiety and depression as side effects from weight loss treatment. Sanofi, who had hoped that the drug would become a blockbuster, are now seeking to reposition it as a type 2 diabetes drug. Trial data show it could help diabetics to achieve their HbA1c goals.
Leave a Comment
Login via Facebook, Yahoo! and Hotmail
Have your full say in the Diabetes Forum
Your comments may be moderated. Please report any spam, illegal, offensive or libellous posts.